DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Darvon (Propoxyphene Hydrochloride) - Summary

 

-- advertisement --

WARNINGS

  • Do not prescribe propoxyphene for patients who are suicidal or addiction-prone.
  • Prescribe propoxyphene with caution for patients taking tranquilizers or antidepressant drugs and patients who use alcohol in excess.
  • Tell your patients not to exceed the recommended dose and to limit their intake of alcohol.

Propoxyphene products in excessive doses, either alone or in combination with other CNS depressants, including alcohol, are a major cause of drug-related deaths. Fatalities within the first hour of overdosage are not uncommon. In a survey of deaths due to overdosage conducted in 1975, in approximately 20% of the fatal cases, death occurred within the first hour (5% occurred within 15 minutes). Propoxyphene should not be taken in doses higher than those recommended by the physician. The judicious prescribing of propoxyphene is essential to the safe use of this drug. With patients who are depressed or suicidal, consideration should be given to the use of non-narcotic analgesics. Patients should be cautioned about the concomitant use of propoxyphene products and alcohol because of potentially serious CNS-additive effects of these agents. Because of its added depressant effects, propoxyphene should be prescribed with caution for those patients whose medical condition requires the concomitant administration of sedatives, tranquilizers, muscle relaxants, antidepressants, or other CNS-depressant drugs. Patients should be advised of the additive depressant effects of these combinations.

Many of the propoxyphene-related deaths have occurred in patients with previous histories of emotional disturbances or suicidal ideation or attempts as well as histories of misuse of tranquilizers, alcohol, and other CNS-active drugs. Some deaths have occurred as a consequence of the accidental ingestion of excessive quantities of propoxyphene alone or in combination with other drugs. Patients taking propoxyphene should be warned not to exceed the dosage recommended by the physician.

 

DARVON SUMMARY

Propoxyphene Hydrochloride, USP is an odorless, white crystalline powder with a bitter taste. It is freely soluble in water.

These products are indicated for the relief of mild to moderate pain. Formulations containing either aspirin or acetaminophen are indicated for the relief of mild to moderate pain, either when pain is present alone or when it is accompanied by fever.

DARVON NEWS HIGHLIGHTS

Media Articles Related to Darvon (Propoxyphene)

New Study On Social And Physical Pain
Source: Health News from Medical News Today [2008.08.28]

Patients Taking Cymbalta® Experienced Reduced Chronic Low Back Pain In New Study
Source: Clinical Trials / Drug Trials News From Medical News Today [2008.08.26]

Opioid Painkillers Sometimes Make Pain Worse, According To Evidence Review
Source: Pain / Anesthetics News From Medical News Today [2008.08.25]

Urogenital Pain - Current Issues And Controversies
Source: Pain / Anesthetics News From Medical News Today [2008.08.25]

Trial Finds Alexander Technique Helps Reduce Backpain
Source: Pain / Anesthetics News From Medical News Today [2008.08.24]

more>>

Published Studies Related to Darvon (Propoxyphene)

Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers. [2004.02.07]

The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. [2000.03]

Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain. [1998.02]

Analgesia after day case laparoscopic sterilisation. A comparison of tramadol with paracetamol/dextropropoxyphene and paracetamol/codeine combinations. [1997.07]

[Analgesic effect and clinical tolerability of the combination of paracetamol 500 mg and caffeine 50 mg versus paracetamol 400 mg and dextropropoxyphene 30 mg in back pain] [1996.09.07]

more>>

Clinical Trials Related to Darvon (Propoxyphene)

Lumbar Stenosis Outcomes Research II [Recruiting]

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain [Active, not recruiting]

An Effectiveness and Safety Study of Two Doses of Acetaminophen Extended Release Caplets in the Treatment of Osteoarthritis of the Hip or Knee [Completed]

Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression [Terminated]

Neuraxial Pethidine After Lumbar Surgery Trial [Recruiting]

more>>

Page last updated: 2008-08-28

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008